Journal of Molecular and Cellular Cardiology 61 (2013) 68–76

Contents lists available at SciVerse ScienceDirect

Journal of Molecular and Cellular Cardiology

j o u r n a l h o me p a g e : w ww . e l s e v i e r . c om / l o c a t e / y j mc c

Review article
Regulation of the cardiac Na +/H + exchanger in health and disease
Shigeo Wakabayashi ⁎, Takashi Hisamitsu, Tomoe Y. Nakamura
Department of Molecular Physiology, National Cerebral and Cardiovascular Center Research Institute, Fujishirodai 5-7-1, Suita, Osaka 565-8565, Japan

a r t i c l e

i n f o

a b s t r a c t

Article history:
Received 21 December 2012
Received in revised form 7 February 2013
Accepted 11 February 2013
Available online 18 February 2013

Keywords:
Na+/H+ exchanger
Hormonal regulation
Calcineurin B homologous protein
Calmodulin
Calcineurin
Cardiac hypertrophy

Contents

The Na+ gradient produced across the cardiac sarcolemma by the ATP-dependent Na+-pump is a constant
source of energy for Na+-dependent transporters. The plasma membrane Na+/H+ exchanger (NHE) is one
such secondary active transporter, regulating intracellular pH, Na+ concentration, and cell volume. NHE1,
the major isoform found in the heart, is activated in response to a variety of stimuli such as hormones and
mechanical stress. This important characteristic of NHE1 is intimately linked to heart diseases, including mal-
adaptive cardiac hypertrophy and subsequent heart failure, as well as acute ischemic-reperfusion injury.
NHE1 activation results in elevation of pH and intracellular Na+ concentration, which potentially enhance
downstream signaling cascades in the myocardium. Therefore, in addition to determining the mechanism un-
derlying regulation of NHE1 activity, it is important to understand how the ionic signal produced by NHE1 is
transmitted to the downstream targets. Extensive studies have identiﬁed many accessory factors that interact
with NHE1. Here, we have summarized the recent progress on understanding the molecular mechanism un-
derlying NHE1 regulation and have shown a possible signaling pathway leading to cardiac remodeling, which
is initiated from NHE1. This article is part of a Special Issue entitled “Na+ Regulation in Cardiac Myocytes”.
© 2013 Elsevier Ltd. All rights reserved.

.

.

.

.
.
.

.
.

.
.
.

.
.

1.
2.
3.

.
.
.
Calcineurin B homologous protein .
Calmodulin .
.
.
.
Lipids
.

.
Introduction
.
Na+/H+ exchanger molecule .
.
.
Regulation of NHE1
.
.
3.1.
.
.
3.2.
.
3.3.
.
Involvement of NHE1 in cardiac disease .
.
Downstream signaling leading to cardiac hypertrophy and heart failure .
.
Conclusion
.
.
.

.
.
.
.
.
.
.

.
.
.
.
.
.
.

.
.
.
.
.
.
.

.
.
.
.
.
.
.

4.
5.
6.
Acknowledgments
Conﬂicts of interest
References
.

.

.

.

.

.
.
.
.
.
.
.

.
.
.
.
.
.
.

.
.
.
.
.
.
.

.
.
.
.
.
.
.

.
.
.
.
.
.
.

.
.
.
.
.
.
.

.
.
.
.
.
.
.

.
.
.
.
.
.
.

.
.
.
.
.
.
.

.

.
.
.
.

.

.
.
.
.

.
.

.
.
.
.

.

.

.
.

.
.
.
.

.

.

.
.

.
.
.
.

.

.

.
.

.
.
.
.

.

.

.
.

.
.
.
.

.
.
.

.
.

.
.
.
.

.
.
.

.
.

.
.
.
.

.
.
.
.

.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

1. Introduction

The plasma membrane Na+/H+ exchanger (NHE) catalyzes acid
extrusion by electroneutral ion exchange, using the energy support

Abbreviations: CaM, calmodulin; CaMKII, Ca2 +/CaM-dependent protein kinase II;
CaN, calcineurin; CHP, calcineurin B homologous protein; DAG, diacylglycerol; IP3,
inositol 1,4,5-trisphosphate; HDAC, histone deacetylase; LID, lipid-interacting do-
main; NCX, Na+/Ca2 + exchanger; NFAT, nuclear factor of activated T cells; NHE,
Na+/H+ exchanger; pHi, intracellular pH; PIP2, phosphatidylinositol 4,5-bisphosphate;
PIP3, phosphatidylinositol (3,4,5)-trisphosphate; SHR, spontaneously hypertensive rat;
TM, transmembrane.

⁎ Corresponding author. Tel.: +81 6 6833 5012x2519; fax: +81 6 6835 5314.

E-mail address: wak@ri.ncvc.go.jp (S. Wakabayashi).

0022-2828/$ – see front matter © 2013 Elsevier Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.yjmcc.2013.02.007

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.

. 68
. 69
. 69
. 69
. 70
. 71
. 71
. 72
. 74
. 74
. 74
. 74

provided by Na+–K+-ATPase. The housekeeping isoform NHE1 is a
key regulator of intracellular pH (pHi), Na+ concentration, and cell vol-
ume in virtually all tissues [1]. In cardiac muscles, intracellular acidosis
results in Na+-overload via NHE1, followed by a sustained increase in
the cytosolic Ca2+ concentration via cardiac Na+/Ca2+ exchanger. In
addition, acidosis itself seriously reduces myoﬁbrilar Ca2+ sensitivity,
resulting in contractile dysfunction. Therefore, it is important for cardiac
muscles to rapidly remove acid load during contraction, particularly
under pathological conditions such as ischemia.

NHE1 has also been implicated in cardiac hypertrophy and chronic
heart disease. In various diseased animal models, the NHE1 inhibitor
had a highly beneﬁcial effect [2]. The involvement of NHE1 in chronic
disease is strongly linked to the ﬁnding that NHE1 is activated in

